Bullish Options Activity in Teva Pharma (TEVA) Continues -Susquehanna

Susquehanna options strategist Alison Edwards notes a continuation of bullish options activity in Teva Pharma (NYSE: TEVA), as an opening investor bought 18k Jan 15 Calls for $1.39, creating ~1 million shares to buy, following yesterday’s bullish Nov24 13 put selling and Jan 17.5 call buying.

You May Also Be Interested In

• Citigroup set to join top banks in Anthropic IPO - Bloomberg
• Bessent on Iran: maximum economic pressure means likely not a kinetic restart
• Deere conference call: 2027 orders up mid-single digits from last year)